Streetbeat News

Regulatory

AGIO

Agios Pharmaceuticals is set to receive $1.1 billion in milestone payments following the FDA approval of Vorasidenib. The payments include $905 million from Royalty Pharma and $200 million from Servier, expected in Q3 2024. This will boost Agios' pro-forma cash position to $1.7 billion as of June 30, 2024, enabling the company to prepare for potential launches of PYRUKYND® (Mitapivat) in Thalassemia in 2025 and Sickle Cell Disease in 2026, and to drive pipeline progress.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:51 pm

APO

VALE

Apollo-managed affiliates and other long-term investors will invest $600 million to acquire a 50% interest in a joint venture entity related to Vale Oman Distribution Center. The transaction is expected to close in the second half of 2024, subject to regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:51 pm

DZSI

DZS Inc. (DZSI) will be delisted from Nasdaq following a decision by the Nasdaq Hearing Panel. The company failed to meet the compliance deadline of August 5, 2024, for periodic filing obligations.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:26 pm

NEXT

NextDecade Corporation (NASDAQ:NEXT) expressed disappointment over the U.S. Court of Appeals for the D.C. Circuit's decision to vacate the Federal Energy Regulatory Commission's (FERC) remand authorization of its Rio Grande LNG Facility. The court ruled that FERC should have issued a supplemental Environmental Impact Statement (EIS). NextDecade is reviewing the decision and assessing its options, while construction on the first three liquefaction trains continues. The company is also evaluating the impact on the timing of a final investment decision for Train 4.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:23 pm

AERT

Aeries Technology, Inc. (NASDAQ:AERT) received a deficiency notification from Nasdaq due to a delayed filing of its Annual Report on Form 10-K for the fiscal year ended March 31, 2024. The company is not in compliance with Nasdaq Listing Rule 5250(c)(1).

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:22 pm

DZSI

DZS shares are trading lower after the company announced it received a delisting notice from the Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:18 pm

SJ

Scienjoy has received a non-compliance notification from Nasdaq for failing to meet the minimum bid price requirement, as its closing bid price has been below $1.00 for 30 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:16 pm

MFI

mF International has received a non-compliance notification from Nasdaq for not meeting the minimum bid price requirement. The company has been issued a notice of deficiency and faces potential delisting.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:13 pm

TRIB

Trinity Biotech plc (NASDAQ:TRIB) has received an extension to demonstrate compliance with Nasdaq's continued listing requirements. The company focuses on human diagnostics and diabetes management solutions, including wearable biosensors.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:12 pm

AOGO

Arogo Capital Acquisition Corp. (NASDAQ:AOGO) has received a delisting notice from Nasdaq due to non-compliance with market value and shareholder requirements. The company has until August 7, 2024, to appeal the decision.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:09 pm